Send me a link:

*Only U.S. numbers are accepted. Text messaging rates may apply.

 Dow Down0.13% Nasdaq Down0.83%

Vanda Pharmaceuticals, Inc. (VNDA)

-NasdaqGM
14.47 Down 0.44(2.95%) 2:46PM EDT - Nasdaq Real Time Price
Get the big picture on all your investments.
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingDec 31, 2013Dec 31, 2012Dec 31, 2011
Total Revenue 33,879   32,727   31,270  
Cost of Revenue -  129   -  
Gross Profit 33,879   32,598   31,270  
Operating Expenses
Research Development28,190  45,446  28,996  
Selling General and Administrative24,594  13,882  11,486  
Non Recurring -   -   -  
Others1,495  1,495  1,495  
Total Operating Expenses -   -   -  
Operating Income or Loss (20,400) (28,225) (10,707)
Income from Continuing Operations
Total Other Income/Expenses Net145  561  461  
Earnings Before Interest And Taxes(20,255)(27,664)(10,246)
Interest Expense -   -   -  
Income Before Tax(20,255)(27,664)(10,246)
Income Tax Expense -   -  (444)
Minority Interest -   -   -  
Net Income From Continuing Ops(20,255)(27,664)(9,802)
Non-recurring Events
Discontinued Operations -   -   -  
Extraordinary Items -   -   -  
Effect Of Accounting Changes -   -   -  
Other Items -   -   -  
Net Income (20,255) (27,664) (9,802)
Preferred Stock And Other Adjustments -   -   -  
Net Income Applicable To Common Shares (20,255) (27,664) (9,802)

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.